Amedisys Completes $22.8 Million Private Placement Financing
01 Dicembre 2003 - 2:00PM
PR Newswire (US)
Amedisys Completes $22.8 Million Private Placement Financing
Funding to Support Amedisys' Growth Strategy BATON ROUGE, La., Dec.
1 /PRNewswire-FirstCall/ -- Amedisys, Inc. (Nasdaq: "AMED" or the
"Company"), one of America's leading home health nursing companies,
today announced that it has completed a $22.8 million private
placement financing. Pursuant to the terms of the purchase
agreements, the Company sold 1.9 million shares of its common stock
at a negotiated price of $12.00 per share. Amedisys will utilize
approximately $4.4 million of the net proceeds from the financing
to pay down debt. The remaining funds will be used for general
corporate purposes and potential acquisitions. "The success of this
financing reflects the confidence that investors maintain in
Amedisys' ability to continue to create shareholder value," said
William F. Borne, Chief Executive Officer. "We intend to continue
our focus on internal growth through further development of our
specialty clinical programs, and further our expansion through
selected acquisitions." "The Company is pleased to reaffirm
previously stated earnings guidance for the year ended December 31,
2003 of $0.72 to $0.75 cents per diluted share." "We will generally
focus our acquisition activity on organizations generating between
$2 million and $20 million a year in revenue in our current
geographic area of activity. We are in preliminary discussions with
several organizations that meet these criteria," concluded Mr.
Borne. Jefferies & Company Inc. and Raymond James &
Associates acted as placement agents for the transaction. The
shares of common stock have not been registered under the
Securities Act of 1933, as amended, or state securities laws and
may not be offered or sold in the United States absent registration
with the Securities and Exchange Commission (SEC) or an applicable
exemption from the registration requirements. Amedisys has agreed
to file a registration statement with respect to the shares within
10 days following the closing. This news release is not an offer to
sell or the solicitation of an offer to buy the securities
discussed herein. Amedisys, Inc., a leading provider of home health
nursing services, is headquartered in Baton Rouge, Louisiana. The
Company had approximately $129 million in revenue in 2002. Its
common stock trades on the Nasdaq Stock Market under the symbol
"AMED". This press release includes statements that may constitute
"forward-looking" statements, usually containing the words
"believe," "estimate," "project," "expect" or similar expressions.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited to,
continued acceptance of the Company's products and services in the
marketplace, competitive factors, changes in government
reimbursement procedures, dependence upon third-party vendors, and
other risks discussed in the Company's periodic filings with the
Securities and Exchange Commission. By making these forward-looking
statements, the Company undertakes no obligation to update these
statements for revisions or changes after the date of this release.
Additional information on this Company can be found on the World
Wide Web http://www.amedisys.com/ Amedisys, Inc. EURO RSCG Life NRP
Chief Financial Officer Investors/Media Greg Browne Brian Ritchie
225.292.2031 212.845.4269 DATASOURCE: Amedisys, Inc. CONTACT: Greg
Browne, Chief Financial Officer of Amedisys, Inc., +1-225-292-2031,
; or Investors-Media, Brian Ritchie of EURO RSCG Life NRP,
+1-212-845-4269, , for Amedisys, Inc. Web site:
http://www.amedisys.com/
Copyright